Ciliary body melanoma is a rare form of eye cancer that arises from the pigment-producing cells in the ciliary body, a part of the eye responsible for producing aqueous humor. Despite its rarity, it poses significant challenges due to its potential for aggressive growth and metastasis. Current research in cancer biology is focused on elucidating the molecular mechanisms underlying its development and progression, with an aim to identify novel therapeutic targets. Treatment typically involves a combination of surgery, radiation therapy, and sometimes chemotherapy, but the prognosis remains guarded, emphasizing the need for more effective and targeted therapies. Advances in genetic profiling and immunotherapy offer promising avenues for personalized treatment strategies, ultimately improving outcomes for patients with ciliary body melanoma.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States